This study will validate the diagnostic accuracy of a cutaneous hydration sensor. This sensor will also be evaluated for its feasibility as a point-of-care device for the assessment of hydration status and its potential to guide hydration therapy in patients with sickle cell disease (SCD).
Enrico Novelli, MD | |
412-916-3416 | |
[email protected] |
Manzoor Mohideen, PhD | |
412-648-6920 | |
[email protected] |
> 12 Years
Not Applicable
Interventional
All
Device
Diagnosis of Sickle Cell Disease (genotypes SS, SC, Sß-thalassemia, SD, SOArab)
Participants must be ≥12-years old
Participants that provide legally effective consent to all study procedures
Participants under 12-years old
Participants being treated with experimental therapies in clinical trials